Immunoproliferative small intestinal disease (IPSID) invariably presents with a malabsorption syndrome resulting from a diffuse and extensive, predominantly plasma cell infiltration of the bowel. 1 Most reported cases have originated from the Mediterranean region, Middle East, Iran, Iraq, Indian subcontinent and South Africa. The IPSID spectrum of disorders includes malignant conditions such as immunoblastic (Mediterranean-type) lymphoma, alpha-chain disease (as-CD) with or without associated lymphoma, and 'benign' conditions characterised by malabsorption with a dense lymphoplasmacytic infiltration of the bowel in patients without lymphoma, and in whom alpha-chains cannot be identified. 2 It has been postulated that diffuse intestinal plasma cell infiltration resulting from possible antigenic stimulation leads in susceptible individuals to the eventual production of as-CD protein;3 and this process may ultimately evolve to lymphoma.4 Although ax-CD protein has been found in the serum in 20-64% of cases of IPSID,5 6 it has been suggested that the vast majority of cases of IPSID are in fact o-CD. 7 The recent report of a nonsecretory form of a-CD8 has prompted a reevaluation of the prevalence of a-CD in IPSID patients.
We have investigated patients with diffuse plasma cell infiltration (PCI) of the bowel in order to determine whether patients with PCI and malabsorption, but without evidence of IPSID-associated lymphoma (IAL) or free alpha-chains in their serum,9 have a non-secretory form of ox-CD. We have determined whether these patients have a deficit in cell-mediated immunity, as has been suggested,' 10 and whether all patients with IAL have evidence of as-CD.
Methods

PATIENTS
Eleven patients (seven women, four men) were studied. All were screened at presentation and at six monthly intervals throughout their course for the presence of free alpha-heavy chains in the serum by a modification of the immunoselection technique of 928
Radl." 12 The main clinical data for each patient at presentation are shown in Table 1 . Three patients had confirmed tc-CD; one (GW) was untreated while another (TC) was in partial remission and asymptomatic with virtually normal histology. The third (CC) was in full remission and off all treatment for eight years. Four subjects had IAL without demonstrable ax-CD protein in the serum. The remaining four patients had a dense plasma cell infiltrate of the bowel, and at the time of study had been followed for a mean of 9-2 years without the development of lymphoma or overt oc-CD. Over an additional 2-7 year period, patients with tx-CD and IAL were recruited into the study, but no change in status of the PCI subgroup (follow up period 11-9 years) was observed. Ten 22 Although it has been accepted that in the absence of detectable alpha-chains in the serum the diagnosis should not be ruled out until a search has been made at the cellular level,4 it is only recently that a non-secretory ot-CD varient (by analogy with non-secretory myelomas)23 has been observed.8 24 This has increased speculation that perhaps all cases of IPSID are in fact either secretory or non-secretory forms of oa-CD. In the present series only those patients with demonstrable alpha-chains in the serum (GW and TC), showed synthesis of an abnormal xx-CD protein band in biopsy cultures. In the case of GW, who had a dense cellular infiltrate, this band of precipitation was much more prominent in the culture supernatant than intracellularly. This is in accordance with the previously observed pattern of rapid export of proteins out of the cell and little or no intracellular storage.12 This band disappeared after treatment, parri passu with normalisation of the serum tests. On the other hand, the a-CD protein precipitate of TC, who was partially treated and whose biopsy showed only minimal abnormality, was more dense intracellularly than in the culture supernate. The explanation for this phenomenon is not clear but may be because of partial postsecretory proteolysis of the deleted fragment of heavy chain. Alternatively, one may postulate that a block in cellular export of the abnormal protein may be one of the early cellular consequences of interventionthat is, a reversal of the normal sequence of events resulting from antibiotic therapy.
Alpha-chains could not be identified by a variety of intracellular or extracellular techniques in the remaining eight patients (four with PCI and four with IAL). Although it is possible that some of the methods used were not sufficiently sensitive to 
